Literature DB >> 23123789

Neurochemical coding compared between varicose axons and cell bodies of myenteric neurons in the guinea-pig ileum.

Dale F Sharrad1, Bao Nan Chen, Simon J H Brookes.   

Abstract

The discrete functional classes of enteric neurons in the mammalian gastrointestinal tract have been successfully distinguished on the basis of the unique combination of molecules and enzymes in their cell bodies ("chemical coding"). Whether the same chemical coding exists in varicose axons of different functional classes has not been systematically tested. In this study, we quantified the coexistence of markers that define classes of nerve cell bodies in the myenteric plexus of the guinea-pig ileum, in varicose axons of the same neurons. Profound differences between the combinations of immunohistochemical markers in myenteric nerve cell bodies and in their varicosities were identified. These discrepancies were particularly notable for classes of neurons that had previously been classified as cholinergic, based on immunoreactivity for choline acetyltransferase (ChAT) in their cell bodies. To detect cholinergic varicose axons of enteric neurons in this study, we used antiserum against the vesicular acetylcholine transporter (VAChT). ChAT-immunoreactivity has been reported to be consistently co-localized with 5-hydroxytryptamine (5-HT) in interneuronal cell bodies, yet only 29±5% (n=4) of 5-HT-immunoreactive varicosities contained vesicular acetylcholine transporter (VAChT). Somatostatin coexists with ChAT-immunoreactivity in a class of descending interneuron but only 21±1% (n=4) of somatostatin-immunoreactive varicosities were VAChT-immunoreactive. Comparable discrepancies were also noted for non-cholinergic markers. The results suggest that chemical coding of cell bodies does not necessarily reflect chemical coding of varicose axon terminals and that the assumption that nerve cell bodies that contain ChAT are functionally cholinergic may be questionable.
Copyright © 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123789     DOI: 10.1016/j.neulet.2012.10.049

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Netrin-1-like-immunoreactivity Coexpresses With DCC and Has a Differential Level in the Myenteric Cholinergic and Nitrergic Neurons of the Adult Mouse Colon.

Authors:  Suh Youn Ko; John T Price; Gregory L Blatch; Kulmira Nurgali
Journal:  J Histochem Cytochem       Date:  2018-12-21       Impact factor: 2.479

2.  Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes: in vitro analyses in mice lacking tryptophan hydroxylase 1.

Authors:  Dante J Heredia; Michael D Gershon; Sang Don Koh; Robert D Corrigan; Takanubu Okamoto; Terence K Smith
Journal:  J Physiol       Date:  2013-10-14       Impact factor: 5.182

Review 3.  A model of the enteric neural circuitry underlying the generation of rhythmic motor patterns in the colon: the role of serotonin.

Authors:  Terence Keith Smith; Sang Don Koh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-10-27       Impact factor: 4.052

4.  Colonic migrating motor complexes, high amplitude propagating contractions, neural reflexes and the importance of neuronal and mucosal serotonin.

Authors:  Terence K Smith; Kyu Joo Park; Grant W Hennig
Journal:  J Neurogastroenterol Motil       Date:  2014-10-30       Impact factor: 4.924

5.  VPAC Receptor Subtypes Tune Purinergic Neuron-to-Glia Communication in the Murine Submucosal Plexus.

Authors:  Candice Fung; Werend Boesmans; Carla Cirillo; Jaime P P Foong; Joel C Bornstein; Pieter Vanden Berghe
Journal:  Front Cell Neurosci       Date:  2017-04-25       Impact factor: 5.505

6.  TRPV1, TRPA1, and TRPM8 are expressed in axon terminals in the cornea: TRPV1 axons contain CGRP and secretogranin II; TRPA1 axons contain secretogranin 3.

Authors:  Leslayann C Schecterson; Alexander A Pazevic; Ruian Yang; Kimberly Matulef; Sharona E Gordon
Journal:  Mol Vis       Date:  2020-08-13       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.